No Data
No Data
No Data
VBI Vaccines Announces Results of Annual General Meeting
VBI Vaccines Shows Promise in Glioblastoma Trial
Express News | VBI Vaccines Inc: Expect to Have Additional Tumor Response Data and Initial Survival Data Throughout Remainder of 2024
Express News | VBI Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study of VBI-1901 in Recurrent Glioblastoma Patients
VBI Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
VBI Vaccines' Promising Glioblastoma Treatment Data
loading...
No Data